What is the current price and pre-market move for PATH stock?

PATH stock is at **$14.34** pre-market on Jan 20 2026, down **-3.04%** with volume **35,725,433.00**, above the 50-day average of **$15.65** and showing higher liquidity.

How does Meyka AI rate PATH stock and why does it matter?

Meyka AI rates PATH with a score of **76.06** (Grade B+, Suggestion: BUY). The grade factors in benchmark and sector comparisons, financial growth, metrics, analyst consensus, and model forecasts.

What are key valuation metrics for PATH stock I should watch?

Watch trailing PE **34.14**, price-to-sales **4.94**, free cash flow yield **4.06%**, and cash per share **$2.59**. These metrics show premium valuation with improving cash generation.

When is the next earnings date for PATH stock and what matters?

UiPath’s next earnings announcement is scheduled for **2026-03-11**. Focus on revenue growth, operating margin, and guidance for automation demand across banking and healthcare sectors.

US Stocks

PATH $14.34 pre-market Jan 20 2026 (NYSE): AI demand keeps outlook mixed

ByDanny Kontos January 20, 2026

Pre-market traders see PATH stock at $14.34, down -3.04% as volumes spike to 35,725,433.00 shares ahead of guidance season. UiPath Inc. (PATH) trades on the NYSE in the United States and the move reflects a mix of recent analyst updates, insider sales, and a market rotation into other AI plays. We assess valuation, recent earnings signals, and Meyka AI forecasts to frame a short-term trading setup and a 12-month outlook for investors.